TP53 and lung carcinoma: The diagnostic sensitivity of cfDNA for lung cancer (including not only TP53 mutations but also other cancer genes) was 68%, with 96% of the specificity and sensitivity rate increased (63%, 83% and 94%) according to tumor stage (for stages I, II and III, respectively) [58].